19 results
Thumbnail

D1.158 - Clinical and Functional Outcomes of Biological Therapy Switching in Severe Asthma: A Real-Life Retrospective Study

Thumbnail

D1.169 - Monitoring of pulmonary function in pregnant women with severe asthma controlled in a monographic asthma and pregnancy unit

Thumbnail

D1.154 - Mepolizumab treatment in a patient with severe eosinophilic granulomatosis with polyangiitis: a case report

Thumbnail

D1.155 - Clinical, Functional and Inflammatory Characteristics of Young Adults with Bronchial Asthma Using Conventional Cigarettes, Electronic Nicotine Delivery Systems and Heated Tobacco Products

Thumbnail

D1.156 - High relevance of upper airways comorbidities in T2 asthma inflammatory burden

Thumbnail

D1.157 - Response to biologic therapy in severe asthma and chronic rhinosinusitis with nasal polyps according to nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity

Thumbnail

D1.159 - Comorbidity of Asthma in Chronic Spontaneous Urticaria: Prevalence and Immunological Insights from a Sri Lankan Cohort

Thumbnail

D1.160 - Perceptions, Attitudes, and Real-World Use of FENO in Allergy and Asthma Practice: Results of a National Survey from Türkiye

Thumbnail

D1.161 - Clinical-epidemiological profile of pediatric difficult-to-control asthma in a tertiary referral center in Brazil

Thumbnail

D1.164 - Evaluation of the use of cyclooxygenase-2 inhibitors in patients with AERD

Thumbnail

D1.165 - Asthma Predisposition and miRNA Expression in Children with Recurrent Infections

Thumbnail

D1.166 - REX-8756 is a First-in-Class Potent and Selective Orthosteric STAT6 Inhibitor That Demonstrates Efficacious Potential and Safety Differentiation in TH2-Mediated Inflammation

Thumbnail

D1.167 - Galectin-3 and Airway Remodelling: Diagnostic and Prognostic Implications in Children

Thumbnail

D1.168 - ASSOCIATION BETWEEN MOLECULAR ALLERGEN SENSITIZATION AND FeNO IN CHILDREN WITH ALLERGIC ASTHMA

Thumbnail

- D1.532 - Phenotypic and Functional Comparison of LAD2, HMC-1.2, and Primary Human Mast Cells

Thumbnail

- D1.529 - Evaluating the Disease-Modifying Potential of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis: An Update on the Pivotal HARBOR Study

Thumbnail

- D1.530 - Patient Experience of Most Burdensome Nonadvanced Systemic Mastocytosis Symptoms From the Pivotal Summit Trial of Bezuclastinib

Thumbnail

- D1.531 - Avapritinib in Indolent Systemic Mastocytosis: Real-world Data from a Greek Case Series

Thumbnail

- D1.533 - Systemic mastocytosis despite normal baseline tryptase: a diagnostic pitfall in recurrent life-threatening anaphylaxis